Clinical Study Site

Aurora, Colorado 80045

1 studies enrolling now · 2 studies all time

What they study most

C3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease, Non-Small Cell Lung Cancer

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 — Recruiting now
• A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G) — Completed